Page last updated: 2024-09-02

triptolide and Esophageal Neoplasms

triptolide has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, W; Hongyi, L; Jian, Y; Lu, W; Pengzhou, K; Ting, Y; Xiaolong, C; Yanchun, M; Yi, W; Yongping, C; Yu, Q	1

Other Studies

1 other study(ies) available for triptolide and Esophageal Neoplasms

Article	Year
Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway. European journal of pharmacology, 2019, May-15, Volume: 851 Topics: Animals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diterpenes; Epoxy Compounds; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Phenanthrenes; Xenograft Model Antitumor Assays	2019

Article

Year

Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway.

European journal of pharmacology, 2019, May-15, Volume: 851

Topics: Animals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diterpenes; Epoxy Compounds; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Phenanthrenes; Xenograft Model Antitumor Assays

2019